Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning

Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning

ObjectiveClinical triage in coronavirus disease 2019 (COVID-19) places a heavy burden on senior clinicians during a pandemic situation. However, risk stratification based on serum biomarker bioprofiling could be implemented by a larger, nonspecialist workforce.MethodMeasures of Complement Activation...

Full description

Bibliographic Details
Main Authors: Laura Wiffen, Leon Gerard D’Cruz, Thomas Brown, Tim W. Higenbottam, Jonathan A. Bernstein, Courtney Campbell, Joseph Moellman, Debajyoti Ghosh, Clive Richardson, Wynne Weston-Davies, Anoop J. Chauhan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
COVID-19
biomarker
nomacopan
cytokine
machine learning
risk stratification
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1192765/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1192765/full

Similar Items